PMID- 31830137 OWN - NLM STAT- MEDLINE DCOM- 20200326 LR - 20200326 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 14 IP - 12 DP - 2019 TI - Differences in receipt of opioid agonist treatment and time to enter treatment for opioid use disorder among specialty addiction programs in the United States, 2014-17. PG - e0226349 LID - 10.1371/journal.pone.0226349 [doi] LID - e0226349 AB - BACKGROUND: Access to adequate treatment for opioid use disorder (OUD) has been a high priority among American policymakers. Elucidation of the sociodemographic and institutional differences associated with the use, or lack thereof, of opioid agonist therapy (OAT) provides greater clarity on who receives OAT. Timely access to care is a further consideration and bears scrutiny as well. METHODS: We draw upon data from the Treatment Episode Data Set-Admissions (TEDS-A) to analyse the relationship between sociodemographic and institutional characteristics and the receipt of opioid agonist treatments and time waiting to enter treatment. RESULTS: Estimates from logistic regression models highlight certain groups which show lower odds of receipt of OAT, including those in precarious housing arrangements, those unemployed or not otherwise in the labor force, and those referred by drug abuse care providers, educational institutions, employers, and the criminal justice system. Groups which showed higher odds of waiting over a week to enter treatment included those who were separated, divorced, or widowed, those working part-time, and those referred by drug abuse care providers, employers, and the criminal justice system. CONCLUSION: Given the efficacy of OAT and the adverse outcomes associated with long waiting times, coordinated effort is needed to understand why these differences persist and how they may be addressed through appropriate policy responses. FAU - Yang, Justin C AU - Yang JC AUID- ORCID: 0000-0003-2881-4906 AD - Department of Public Health & Primary Care, Institute of Public Health, University of Cambridge, Cambridge, England, United Kingdom. AD - Department and Epidemiology and Applied Clinical Research, Division of Psychiatry, Faculty of Brain Sciences, University College London, London, England, United Kingdom. FAU - Roman-Urrestarazu, Andres AU - Roman-Urrestarazu A AUID- ORCID: 0000-0002-2405-9432 AD - Department of Public Health & Primary Care, Institute of Public Health, University of Cambridge, Cambridge, England, United Kingdom. AD - Department of International Health, Care and Public Health Research Institute, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands. FAU - Brayne, Carol AU - Brayne C AUID- ORCID: 0000-0001-5307-663X AD - Department of Public Health & Primary Care, Institute of Public Health, University of Cambridge, Cambridge, England, United Kingdom. LA - eng PT - Journal Article DEP - 20191212 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Analgesics, Opioid) SB - IM MH - Adolescent MH - Adult MH - Analgesics, Opioid/*agonists MH - Behavior, Addictive/*drug therapy MH - Female MH - Humans MH - Male MH - Middle Aged MH - Opiate Substitution Treatment/*methods MH - Opioid-Related Disorders/*drug therapy/epidemiology MH - Time-to-Treatment MH - United States/epidemiology MH - Young Adult PMC - PMC6907755 COIS- The authors have declared that no competing interests exist. EDAT- 2019/12/13 06:00 MHDA- 2020/03/27 06:00 PMCR- 2019/12/12 CRDT- 2019/12/13 06:00 PHST- 2019/05/09 00:00 [received] PHST- 2019/11/25 00:00 [accepted] PHST- 2019/12/13 06:00 [entrez] PHST- 2019/12/13 06:00 [pubmed] PHST- 2020/03/27 06:00 [medline] PHST- 2019/12/12 00:00 [pmc-release] AID - PONE-D-19-13139 [pii] AID - 10.1371/journal.pone.0226349 [doi] PST - epublish SO - PLoS One. 2019 Dec 12;14(12):e0226349. doi: 10.1371/journal.pone.0226349. eCollection 2019.